Nicole Verdun, FDA super office director
Platform designations: FDA's new cell and gene therapy super office director sees potential
FDA’s Nicole Verdun has high expectations for a new designation that could be crucial for cell and gene therapy sponsors.
There’s “a lot of opportunity” …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
